Transfusion of white-cell-containing allogeneic blood components and postoperative wound infection: Effect of confounding factors

Transfusion Medicine

Volumn 8, Issue 1, 1998, Pages 29-36

  Vamvakas, E C ^a,b   Carven, J H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bacterial; Immunomodulation; Immunosuppression; Infection; Perioperative; Pest ope rative; Septic complication; Surgical; Surgical site; Transfusion; Wound

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ANESTHESIA; APHERESIS; ARTICLE; BLEEDING; BLOOD COMPONENT THERAPY; CANCER STAGING; COHORT ANALYSIS; COLORECTAL TUMOR; COMORBIDITY; DISEASE PREDISPOSITION; EPIDEMIOLOGY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HYPOTENSION; LEUKOCYTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEROPERATIVE COMPLICATION; RADIOTHERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; THROMBOCYTE TRANSFUSION;

AGED; ANESTHESIA; ANTINEOPLASTIC AGENTS; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD LOSS, SURGICAL; COHORT STUDIES; COLORECTAL NEOPLASMS; COMORBIDITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE SUSCEPTIBILITY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; HYPOTENSION; INTRAOPERATIVE COMPLICATIONS; LEUKOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PLATELET TRANSFUSION; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 0031944761     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1998.00122.x     Document Type: Article

References (10)

1. Blajchman, M.A. (1997) Allogeneic blood transfusions, immunomodulation and postoperative bacterial infection: do we have the answers yet? Transfusion, 37, 121-125.
2. Blumberg, N. & Heal, J. (1994) Effects of transfusion on immune function: cancer recurrence and infection. Archives of Pathology and Laboratory Medicine, 118, 371-379.
3. Bordin, J.O., Heddle, N.M. & Blajchman, M.A. (1994) Biologic effects of leukocytes present in transfused cellular blood products. Blood, 84, 1703-1721.
4. Busch, O.R.C., Hop, W.C.J., Hoynek van Papendrecht, M.A.W., Marquet, R.L. & Jeekel, J. (1993) Blood transfusion and prognosis in colorectal cancer. New England Journal of Medicine, 328, 1372-1376.
5. Centers for Disease Control. (1994) National Nosocomial Infections Surveillance System Information Packet. US Department of Health and Human Services, Atlanta.
6. Charlson, M.E., Pompei, P., Ales, K.L. & MacKenzie, C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation. Journal of Chronic Diseases, 40, 373-383.
7. Fleiss, J.L., Tytun, A. & Ury, H.K. (1980) A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics, 36, 343-346.
8. Ford, CD., van Moorleghem, G. & Menlove, R.L. (1993) Blood transfusions and postoperative wound infection. Surgery, 113, 603-607.
9. Vamvakas, E.C., Carven, J.H. & Hibberd, P.L. (1996) Blood transfusion and infection after colorectal cancer surgery. Transfusion, 36, 1000-1008.
10. Vamvakas, B.C. & Moore, S.B. (1994) Blood transfusion and postoperative septic complications. Transfusion, 34, 714-727.